CRH Medical Debt to Equity Ratio 2012-2019 | CRHM

Current and historical debt to equity ratio values for CRH Medical (CRHM) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. CRH Medical debt/equity for the three months ending September 30, 2019 was 0.58.
CRH Medical Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2019-09-30 $0.07B $0.12B 0.58
2019-06-30 $0.07B $0.13B 0.50
2019-03-31 $0.06B $0.13B 0.46
2018-12-31 $0.07B $0.14B 0.49
2018-09-30 $0.07B $0.13B 0.50
2018-06-30 $0.07B $0.14B 0.49
2018-03-31 $0.06B $0.12B 0.48
2017-12-31 $0.06B $0.13B 0.46
2017-09-30 $0.06B $0.12B 0.49
2017-06-30 $0.04B $0.10B 0.39
2017-03-31 $0.06B $0.13B 0.48
2016-12-31 $0.04B $0.10B 0.39
2016-09-30 $0.04B $0.09B 0.47
2016-06-30 $0.05B $0.09B 0.53
2016-03-31 $0.03B $0.06B 0.45
2015-12-31 $0.03B $0.06B 0.47
2015-09-30 $0.02B $0.05B 0.45
2015-06-30 $0.03B $0.04B 0.59
2015-03-31 $0.04B $0.04B 0.83
2014-12-31 $0.04B $0.02B 2.10
2014-09-30 $0.00B $0.01B 0.00
2014-06-30 $0.00B $0.01B 0.00
2014-03-31 $0.00B $0.01B 0.00
2013-12-31 $0.00B $0.01B 0.00
2013-09-30 $0.00B $0.01B 0.00
2013-06-30 $0.00B $0.01B 0.00
2013-03-31 $0.00B $0.01B 0.00
2012-12-31 $0.00B $0.01B 0.00
2012-09-30 $0.00B 0.00
2012-06-30 $0.00B 0.00
2012-03-31 $0.00B 0.00
2011-12-31 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.240B $0.113B
CRH Medical Corporation is a North American company focused on providing gastroenterologists throughout the United States with innovative services and products for the treatment of gastrointestinal diseases. In 2014, CRH became a full-service gastroenterology anesthesia company that provides anesthesia services for patients undergoing endoscopic procedures in ambulatory surgical centers. At the end of 2018, CRH had completed 20 anesthesia acquisitions and served 46 ambulatory surgical centers in ten states, performing approximately 305,000 procedures annually. In addition, CRH owns the CRH O'Regan System, a single-use, disposable, hemorrhoid banding technology that is safe and highly effective in treating all grades of hemorrhoids. CRH distributes the O'Regan System, treatment protocols, operational and marketing expertise as a complete, turnkey package directly to gastroenterology practices, creating meaningful relationships with the gastroenterologists it serves.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $128.518B 26.62
Intuitive Surgical (ISRG) United States $66.992B 52.65
Edwards Lifesciences (EW) United States $48.522B 44.06
Fresenius Medical Care AG KGaA (FMS) Germany $22.240B 15.05
IDEXX Laboratories (IDXX) United States $21.694B 52.47
Olympus (OCPNY) Japan $19.694B 0.00
DexCom (DXCM) United States $18.656B 167.07
Teleflex (TFX) United States $16.661B 33.82
Sysmex ADR (SSMXY) Japan $14.347B 38.62
Hologic (HOLX) United States $14.252B 21.78
SONOVA HOLDING (SONVY) Switzerland $14.047B 0.00
STERIS (STE) Ireland $12.881B 28.45
Varian Medical Systems (VAR) United States $12.865B 30.50
Masimo (MASI) United States $8.354B 49.88
ABIOMED (ABMD) United States $8.211B 44.68
Globus Medical (GMED) United States $5.802B 35.80
SARTORIUS AG (SARTF) Germany $5.614B 49.28
Penumbra (PEN) United States $5.563B 181.04
Integra LifeSciences Holdings (IART) United States $5.300B 22.78
Elekta AB (EKTAY) Sweden $4.718B 36.32
Wright Medical Group (WMGI) Netherlands $3.779B 229.08
LivaNova (LIVN) United Kingdom $3.692B 26.58
Tandem Diabetes Care (TNDM) United States $3.590B 0.00
Nevro (NVRO) United States $3.394B 0.00
Cantel Medical (CMD) United States $3.155B 30.88
Integer Holdings (ITGR) United States $2.577B 17.64
Nihon Kohden (NHNKY) Japan $2.330B 23.44
Glaukos (GKOS) United States $2.058B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.557B 30.64
Inogen (INGN) United States $1.556B 49.13
Veracyte (VCYT) United States $1.392B 0.00
Tactile Systems Technology (TCMD) United States $1.282B 146.46
Mesa Laboratories (MLAB) United States $1.089B 40.38
Silk Road Medical (SILK) United States $1.072B 0.00
Natus Medical (NTUS) United States $1.053B 25.32
OPKO Health (OPK) United States $1.038B 0.00
Luminex (LMNX) United States $0.974B 0.00
CryoLife (CRY) United States $0.968B 99.31
Accelerate Diagnostics (AXDX) United States $0.898B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.867B 28.80
Pacific Biosciences Of California (PACB) United States $0.844B 0.00
Intersect ENT (XENT) United States $0.678B 0.00
AxoGen (AXGN) United States $0.667B 0.00
OrthoPediatrics (KIDS) United States $0.662B 0.00
AngioDynamics (ANGO) United States $0.585B 21.00
Quotient (QTNT) Switzerland $0.569B 0.00
Si-Bone (SIBN) United States $0.493B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.447B 13.52
ViewRay (VRAY) United States $0.429B 0.00
Sientra (SIEN) United States $0.422B 0.00
Alphatec Holdings (ATEC) United States $0.403B 0.00
GenMark Diagnostics (GNMK) United States $0.308B 0.00
IRadimed (IRMD) United States $0.295B 41.40
Semler Scientific (SMLR) United States $0.294B 40.90
Accuray (ARAY) United States $0.250B 0.00
Fluidigm (FLDM) United States $0.220B 0.00
SeaSpine Holdings (SPNE) United States $0.210B 0.00
RTI Surgical (RTIX) United States $0.178B 48.20
Restoration Robotics (VERO) Canada $0.134B 0.00
EDAP TMS S.A (EDAP) France $0.132B 34.92
Spectral Diagnostics (EDTXF) Canada $0.129B 0.00
ConforMIS (CFMS) United States $0.106B 0.00
Second Sight Medical Products (EYES) United States $0.097B 0.00
Neuronetics (STIM) United States $0.080B 0.00
Vermillion (VRML) United States $0.074B 0.00
Apollo Endosurgery (APEN) United States $0.060B 0.00
Sensus Healthcare (SRTS) United States $0.060B 0.00
T2 Biosystems (TTOO) United States $0.054B 0.00
Ekso Bionics Holdings (EKSO) United States $0.044B 0.00
Bioanalytical Systems (BASI) United States $0.042B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.040B 0.00
Neovasc (NVCN) Canada $0.025B 0.00
ReWalk Robotics (RWLK) Israel $0.018B 0.00
OBALON THERPTCS (OBLN) United States $0.015B 0.00
DarioHealth (DRIO) Israel $0.013B 0.00
Helius Medical Technologies (HSDT) United States $0.013B 0.00
Avinger (AVGR) United States $0.013B 0.00
Nanovibronix (NAOV) United States $0.013B 0.00
Ra Medical Systems (RMED) United States $0.011B 0.00
Lianluo Smart (LLIT) China $0.009B 0.00
ENDRA Life Sciences (NDRA) United States $0.008B 0.00
Dynatronics (DYNT) United States $0.006B 0.00
Allied Healthcare Products (AHPI) United States $0.004B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Sunshine Heart Inc (CHFS) United States $0.004B 0.00
Viveve Medical (VIVE) United States $0.001B 0.00